COSSU, MARIA VITTORIA
COSSU, MARIA VITTORIA
Universita' degli Studi di MILANO
Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV
2024 M.V. Cossu, A. D'Avolio, C. Gervasoni, A. Giacomelli, D. Cattaneo, D. Moschese
Treatment Experienced People Living with HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings from an Italian Multicenter Cohort
2024 V. Iannone, A. Ciccullo, D. Moschese, A. Giacomelli, M. Fabbiani, F. Lagi, C. Papalini, A. De Vito, M.V. Cossu, S. Di Giambenedetto, A. Borghetti
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy
2024 A. Rizzo, D. Moschese, F. Salari, A. Giacomelli, L. Morelli, M.V. Cossu, C. Fusetti, F. Petri, G. Casalini, A. Poloni, S. Lazzarin, A. Gori, S. Antinori, M.R. Gismondo, A. Lombardi, G. Rizzardini
Analyzing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicenter cohort of virologically-suppressed PLWHIV
2023 A. Ciccullo, G. Baldin, G. Sterrantino, M.V. Cossu, A. Giacomelli, F. Lagi, D. Farinacci, V. Iannone, R. Anna Passerotto, A.F. Capetti, S. Antinori, C. Mussini, V. Borghi, S. DI GIAMBENEDETTO
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy
2023 A. Rizzo, G. Pozza, F. Salari, A. Giacomelli, D. Mileto, M.V. Cossu, A. Mancon, G. Gagliardi, M. Bianchi, V. Micheli, A. Capetti, S. Antinori, M.R. Gismondo, P. Olivieri, A. Lombardi
Decay rate of antiS1/S2 IgG serum levels after 6 months of BNT162b2 vaccination in a cohort of COVID-19-naive and COVID-19-experienced subjects
2022 F. Borgonovo, C.A. Stangalini, C. Tinelli, C. Mariani, D. Mileto, M.V. Cossu, L. Abbati, L. Bilardo, G. Gagliardi, M. Cutrera, M. Pellicciotta, L. Armiento, G. Dedivitiis, A.F. Capetti, G. Rizzardini
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens
2021 D. Cattaneo, M. Fusi, V. Micheli, C. Resnati, P. Meraviglia, M.V. Cossu, S. Vimercati, G.C. Bisinella, S. Baldelli, S. Antinori, C. Gervasoni
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
2021 F. Lescure, H. Honda, R.A. Fowler, J.S. Lazar, G. Shi, P. Wung, N. Patel, O. Hagino, I.J. Bazzalo, M.M. Casas, S.A. Nuñez, Y. Pere, C.M. Ibarrola, M.A. Solis Aramayo, M.C. Cuesta, A.E. Duarte, P.M. Gutierrez Fernandez, M.A. Iannantuono, E.A. Miyazaki, J.P. Silvio, D.G. Scublinsky, A. Bales, D. Catarino, E. Fiss, S. Mohrbacher, V. Sato, A. Baylao, A. Cavalcante, F. Correa, C.A. de Andrade, J. Furtado, N. Ribeiro Filho, V. Telles, L.T. Trevelin, R. Vipich, R. Boldo, P. Borges, S. Lobo, G. Luckemeyer, L. Machado, M.B. Alves, A.C. Iglessias, M.M. Lago, D.W. Santos, H. Chapdelaine, E.L. Falcone, R. Jamal, M. Luong, M. Durand, S. Doucet, F. Carrier, B.A. Coburn, L. Del Sorbo, S.L. Walmsley, S. Belga, L.Y. Chen, A.D. Mah, T. Steiner, A.J. Wright, J. Hajek, N. Adhikari, R.A. Fowler, N. Daneman, K.A. Khwaja, J. Shahin, C. Gonzalez, R. Silva, M. Lindh, G. Maluenda, P. Fernandez, M. Oyonarte, M. Lasso, A. Boyer, D. Bronnimann, H. Bui, C. Cazanave, H. Chaussade, A. Desclaux, M. Ducours, A. Duvignaud, D. Malvy, L. Martin, D. Neau, D. Nguyen, T. Pistone, G. Soubrane-Wirth, J. Leitao, C. Allavena, C. Biron, S. Bouchez, B. Gaborit, A. Gregoire, P. Le Turnier, A. Lecompte, R. Lecomte, M. Lefebvre, F. Raffi, D. Boutoille, P.H. Morineau, R. Guéry, E. Chatelus, N. Dumoussaud, R. Felten, F. Luca, B. Goichot, F. Schneider, M. Taquet, M. Groh, M. Roumier, M. Neuville, A. Bachelard, V. Isernia, F. Lescure, B. Phung, A. Rachline, A. Sautereau, D. Vallois, Y. Bleher, D. Boucher, C. Coudon, J. Esnault, T. Guimard, S. Leautez-Nainville, D. Merrien, M. Morrier, P. Motte-Vincent, R. Gabeff, H. Leclerc, C. Cozic, R. Decours, R. Février, G. Colin, S. Abgrall, D. Vignes, R. Sterpu, M. Kuellmar, M. Meersch-Dini, R. Weiss, A. Zarbock, C. Antony, M. Berger, T. Brenner, C. Taube, F. Herbstreit, S. Dolff, M. Konik, K. Schmidt, M. Zettler, O. Witzke, B. Boell, J. Garcia Borrega, P. Koehler, T. Zander, F. Dusse, O. Al-Sawaf, P. Köhler, D. Eichenauer, M. Kochanek, A. Shimabukuro-Vornhagen, S. Mellinghoff, A. Claßen, J. Heger, C. Meyer-Schwickerath, P. Liedgens, K. Heindel, A. Belkin, A. Biber, M. Gilboa, I. Levy, V. Litachevsky, G. Rahav, A. Finesod Wiedner, T. Zilberman-Daniels, Y. Oster, J. Strahilevitz, S. Sviri, E.M. Baldissera, C. Campochiaro, G. Cavalli, L. Dagna, G. De Luca, E. Della Torre, A. Tomelleri, D. Bernasconi De Luca, A.F. Capetti, M. Coen, M.V. Cossu, M. Galli, A. Giacomelli, G.A. Gubertini, S. Rusconi, G.J. Burastero, M. Digaetano, G. Guaraldi, M. Meschiari, C. Mussini, C. Puzzolante, S. Volpi, M. Aiello, A. Ariani, A.A. Chetta, A. Frizzelli, A. Ticinesi, D. Tuttolomondo, S. Aliberti, F.B. Blasi, M.F. Di Pasquale, S. Misuraca, T. Pilocane, E. Simonetta, A.M. Aghelmo, C. Angelini, E. Brunetta, G.W. Canonica, M. Ciccarelli, S. Dal Farra, M. De Santis, S. Ferri, M. Folci, G.M. Guidelli, E.M. Heffler, F. Loiacono, G. Malipiero, G. Paoletti, R. Pedale, F.A. Puggioni, F. Racca, A. Zumbo, M. Satou, H. Honda, T. Lisun, D. Protsenko, N. Rubtsov, I. Beloglazova, D. Fomina, M. Lysenko, S. Serdotetskova, V. Firstov, I. Gordeev, I. Kokorin, K. Komissarova, N. Lapochkina, E. Luchinkina, V. Malimon, S. Mamedguseyinova, K. Polubatonova, N. Suvorova, J. Arribas, A.M. Borobia Perez, F. de la Calle Prieto, J.C. Figueira, R. Motejano Sanchez, M. Mora-Rillo, C. Prados Sanchez, J. Queiruga Parada, F. Fernandez Arnalich, M. Guerro Barrientos, A. Bendala Estrada, A. Caballero Marcos, M.E. Garcia Leoni, R. García-Martínez, A.M. Collado, P. Munoz Garcia, A. Torres do Rego, M.V. Villalba García, A. Burrillo, M. Valerio Minero, P. Gijon Vidaurreta, S. Infante Herrero, E. Velilla, M. Machado, M. Olmedo, B. Pinilla, B. Almirante Gragera, M.D.L.E. Cañas Ruano, S. Contreras Medina, A. Cortés Herrera, V. Falcó Ferrer, R. Ferrer Roca, X. Nuvials Casals, E. Ribera Pascuet, P. Suanzes Diez, P. Rebollo Castro, F. Garcia Alcaide, A. Soriano, A. Oliver Caldes, A. González Cordón, C. Cardozo, L. De la Mora Cañizo, R. Pena López, S. Chamorro, C. Crespillo-Andujar, R. Escudero Sanchez, J. Fortún-Abete, B. Monge-Maillo, A. Moreno Zamora, F. Norman, M. Sanchez Conde, S. Serrano Villar, P. Vizcarra
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
2021 F. Borgonovo, M. Passerini, M. Piscaglia, V. Morena, A. Giacomelli, L. Oreni, G. Dedivitiis, A. Lupo, S. Falvella, M.V. Cossu, A.F. Capetti
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic
2021 A. Giacomelli, C. Bonazzetti, F. Conti, L. Pezzati, L. Oreni, V. Micheli, A. Mancon, S. Vimercati, M. Albrecht, M. Passerini, M.V. Cossu, A.F. Capetti, P. Meraviglia, S. Antinori, G. Rizzardini, M. Galli, A.L. Ridolfo
Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression
2020 A. Antinori, M.V. Cossu, B. Menzaghi, G. Sterrantino, N. Squillace, V. Di Cristo, A. Cattelan, E. Focà, A. Castagna, G. Orofino, D. Valenti, G. D'Ettore, L. Aprea, S. Ferrara, M.E. Locatelli, G. Madeddu, E. Pontali, P. Scerbo, B. Rossetti, A. Uglietti, R. Termini, F. Rucci, A. Gori, D. Mancusi
96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation
2020 V. Di Cristo, F. Adorni, R. Maserati, M. Annovazzi Lodi, G. Bruno, P. Maggi, A. Volpe, P. Vitiello, C. Abeli, S. Bonora, M. Ferrara, M.V. Cossu, M.L. Oreni, E. Colella, S. Rusconi
Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post_treatment hospitalisation status
2020 S. Antinori, M.V. Cossu, A.L. Ridolfo, R. Rech, C. Bonazzetti, G. Pagani, G. Gubertini, M. Coen, C. Magni, A. Castelli, B. Borghi, R. Colombo, R. Giorgi, E. Angeli, D. Mileto, L. Milazzo, S. Vimercati, M. Pellicciotta, M. Corbellino, A. Torre, S. Rusconi, L. Oreni, M.R. Gismondo, A. Giacomelli, L. Meroni, G. Rizzardini, M. Galli
Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression
2020 A. Antinori, M.V. Cossu, B. Menzaghi, G. Sterrantino, N. Squillace, V. Di Cristo, A. Cattelan, E. Foca, A. Castagna, G. Orofino, D. Valenti, G. D'Ettore, L. Aprea, S. Ferrara, M.E. Locatelli, G. Madeddu, E. Pontali, P. Scerbo, B. Rossetti, A. Uglietti, R. Termini, F. Rucci, A. Gori, D. Mancusi
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy
2020 V. Morena, L. Milazzo, L. Oreni, G. Bestetti, T. Fossali, C. Bassoli, A. Torre, M.V. Cossu, C. Minari, E. Ballone, A. Perotti, D. Mileto, F. Niero, S. Merli, A. Foschi, S. Vimercati, G. Rizzardini, S. Sollima, L. Bradanini, L. Galimberti, R. Colombo, V. Micheli, C. Negri, A.L. Ridolfo, L. Meroni, M. Galli, S. Antinori, M. Corbellino
Single tablet regimen with abacavir/lamivudine/dolutegravir compared with two-drug regimen with lamivudine and dolutegravir as different strategies of simplification from a multicenter HIV cohort study
2019 G. Baldin, A. Ciccullo, S. Rusconi, G. Madeddu, G. Sterrantino, A. Freedman, A. Giacometti, L. Celani, A. Latini, B. Rossetti, M.V. Cossu, A. Giacomelli, F. Lagi, A. Capetti, S. Di Giambenedetto
Long term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicenter cohort of HIV1-infected, virologically suppressed patients
2019 G. Baldin, A. Ciccullo, S. Rusconi, A. Capetti, G. Sterrantino, M. Colafigli, G. D'Ettorre, A. Giacometti, M.V. Cossu, A. Borghetti, W. Gennari, C. Mussini, V. Borghi, S. Di Giambenedetto
An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents
2019 V. Giacomet, M.V. Cossu, A.F. Capetti, G.V. Zuccotti, G. Rizzardini
Cohort profile : The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE)
2019 A. Ciccullo, G. Baldin, A. Capetti, V. Borghi, G. Sterrantino, A. Latini, G. Madeddu, L. Celani, F. Vignale, B. Rossetti, A. Dusina, M.V. Cossu, S. Restelli, W. Gennari, F. Lagi, A. Giacomelli, M. Colafigli, L. Brescini, A. Borghetti, C. Mussini, S. Rusconi, S. Di Giambenedetto
Dolutegravir plus rilpivirine as a switch option in cART-experienced patients : 96-week data
2018 A.F. Capetti, M.V. Cossu, G. Sterrantino, G. Barbarini, S. Di Giambenedetto, G.V. De Socio, G. Orofino, A. Di Biagio, B.M. Celesia, S. Rusconi, B. Argenteri, G. Rizzardini